[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf

上传人:任我行 文档编号:27857 上传时间:2022-06-24 发布时间:2019-03-20 格式:PDF 页数:5 大小:727.02KB
下载 相关 举报
[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf_第1页
第1页 / 共5页
[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf_第2页
第2页 / 共5页
[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf_第3页
第3页 / 共5页
[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf_第4页
第4页 / 共5页
[20190125]LSB10225_“秘密销售”是否触发了《美国发明法案》规定的销售专利限制?.pdf_第5页
第5页 / 共5页
亲,该文档总共5页,全部预览完了,如果喜欢就下载吧!
资源描述

1、CRS Legal Sidebar Prepared for Members and Committees of Congress Legal SidebarLegal Sidebari i Do “Secret Sales” Trigger the On-Sale Bar to Patentability under the America Invents Act? Updated January 25, 2019 UPDATE (January 25, 2019): On January 22, 2019, the Supreme Court issued its opinion in H

2、elsinn Healthcare S.A. v. Teva Pharmaceuticals Inc. Justice Thomass opinion for a unanimous Court held that a commercial sale of an invention to a third party who is required to keep an invention confidential places an invention “on sale” within the meaning of the Patent Act. The Court reaffirmed it

3、s holding in Pfaff v. Wells Electronics, Inc. that a patentable invention is considered “on sale” if it is (1) “the subject of a commercial offer for sale”; and (2) “ready for patenting.” More specifically, the Court concluded that the 2011 America Invents Acts addition of a new catchall category of

4、 prior art that is “otherwise available to the public” did not alter the “well-settled meaning” of the on-sale bar, which requires an inventor to apply for a patent within one year after an invention is on sale. The original post on Helsinn v. Teva, from December 3, 2018, is reproduced below. In gen

展开阅读全文
相关资源
猜你喜欢
相关搜索
资源标签

当前位置:首页 > 法规条令 > CRS 美国国会研究处报告